Business Description
Onconova Therapeutics Inc
NAICS : 325412
SIC : 2834
Share Class Description:
ONTXW: Warrants (01/08/2021)Description
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -0.23 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -148.15 | |||||
| Beneish M-Score | 108.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -18.6 | |||||
| 3-Year EBITDA Growth Rate | 23.5 | |||||
| 3-Year EPS without NRI Growth Rate | 25.3 | |||||
| 3-Year FCF Growth Rate | 24.6 | |||||
| 3-Year Book Growth Rate | 0.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 63.57 | |||||
| Future 3-5Y Total Revenue Growth Rate | 13.37 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.07 | |||||
| Quick Ratio | 1.07 | |||||
| Cash Ratio | 0.65 | |||||
| Days Sales Outstanding | 708.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.2 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -10661.06 | |||||
| Net Margin % | -62294.25 | |||||
| ROA % | -736.98 | |||||
| ROIC % | -2598.58 | |||||
| ROC (Joel Greenblatt) % | -130945.65 | |||||
| ROCE % | -246.15 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 18.39 | |||||
| EV-to-EBIT | -0.35 | |||||
| EV-to-EBITDA | -0.35 | |||||
| EV-to-Revenue | 37.38 | |||||
| EV-to-FCF | -0.28 | |||||
| Earnings Yield (Greenblatt) % | -285.71 | |||||
| FCF Yield % | -217.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ONTXW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Onconova Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 0.17 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Onconova Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Onconova Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Onconova Therapeutics Inc Frequently Asked Questions
What is Onconova Therapeutics Inc(ONTXW)'s stock price today?
The current price of ONTXW is $0.07. The 52 week high of ONTXW is $0.17 and 52 week low is $0.00.
When is next earnings date of Onconova Therapeutics Inc(ONTXW)?
The next earnings date of Onconova Therapeutics Inc(ONTXW) is 2025-02-14 Est..
Does Onconova Therapeutics Inc(ONTXW) pay dividends? If so, how much?
Onconova Therapeutics Inc(ONTXW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers